US Stock MarketDetailed Quotes

RNAC Cartesian Therapeutics

Watchlist

18.160
+0.250+1.40%

Trading Nov 29 09:49 ET

461.53MMarket Cap-392P/E (TTM)

Cartesian Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

248.57%13.69M

-45.99%-14.45M

-81.60%-15.92M

-61.74%-51.16M

-96.52%-23.29M

-311.69%-9.22M

19.36%-9.9M

26.12%-8.77M

47.62%-31.63M

62.34%-11.85M

Net income from continuing operations

-168.64%-24.18M

221.51%13.84M

-162.31%-56.82M

-721.02%-219.71M

-3,114.73%-177.66M

-14.05%-9M

-232.39%-11.39M

-175.28%-21.66M

237.73%35.38M

-51.85%5.89M

Operating gains losses

-86.05%-5.67M

161.63%3.91M

43.42%5.85M

756.57%138.07M

1,157.92%143.38M

-146.60%-3.05M

-236.45%-6.34M

121.86%4.08M

-999.06%-21.03M

-50.66%-13.55M

Depreciation and amortization

51.32%286K

11.36%196K

-11.17%183K

-34.50%843K

12.86%272K

-46.00%189K

-48.99%176K

-41.31%206K

2.80%1.29M

-39.90%241K

Deferred tax

----

---19M

----

--0

----

Other non cash items

4,300.28%15.75M

-438.50%-1.9M

4,790.91%39.81M

795.59%20.51M

3,120.58%18.78M

-33.33%358K

13.56%561K

20.41%814K

7.46%2.29M

16.83%583K

Change In working capital

76,008.82%25.81M

-1,068.25%-32.08M

-213.69%-6.37M

108.23%4.97M

44.48%-3.91M

-101.45%-34K

111.07%3.31M

121.75%5.6M

-25.28%-60.38M

81.41%-7.04M

-Change in receivables

9,019.52%29.7M

-1,488.72%-31.14M

315.89%4.48M

481.41%907K

26.65%-2.08M

-101.95%-333K

113.31%2.24M

-61.03%1.08M

105.80%156K

-9.38%-2.83M

-Change in prepaid assets

-146.75%-2.09M

43.23%1.2M

8,360.00%1.65M

-151.19%-1.27M

-144.50%-1.24M

-1,307.14%-845K

168.05%835K

-102.34%-20K

270.30%2.47M

394.90%2.78M

-Change in payables and accrued expense

-185.28%-1.81M

-294.04%-1.73M

-53.06%-7.06M

-95.71%73K

-0.24%1.68M

320.60%2.12M

-74.35%890K

-85.59%-4.61M

18.02%1.7M

109.72%1.68M

-Change in other working capital

--0

37.00%-412K

-159.37%-5.44M

108.12%5.26M

73.77%-2.27M

92.94%-976K

95.73%-654K

134.06%9.16M

-42.23%-64.71M

49.26%-8.66M

Cash from discontinued investing activities

Operating cash flow

248.57%13.69M

-45.99%-14.45M

-81.60%-15.92M

-61.74%-51.16M

-96.52%-23.29M

-311.69%-9.22M

19.36%-9.9M

26.12%-8.77M

47.62%-31.63M

62.34%-11.85M

Investing cash flow

Cash flow from continuing investing activities

-6.2M

-13,125.00%-1.59M

-102.14%-602K

330.70%34.61M

18.36%6.5M

87.88%-12K

194.65%28.12M

12.47%-15M

-43.54%5.49M

Net PPE purchase and sale

---6.2M

-13,125.00%-1.59M

-363.08%-602K

82.85%-206K

69.67%-64K

--0

87.88%-12K

71.43%-130K

-10.69%-1.2M

24.10%-211K

Net business purchase and sale

----

--6.56M

----

--0

----

Net investment purchase and sale

--0

304.72%28.25M

--0

182.54%28.25M

14.04%-13.8M

-43.00%5.7M

Cash from discontinued investing activities

Investing cash flow

---6.2M

-13,125.00%-1.59M

-102.14%-602K

330.70%34.61M

18.36%6.5M

--0

87.88%-12K

194.65%28.12M

12.47%-15M

-43.54%5.49M

Financing cash flow

Cash flow from continuing financing activities

602.21%124.49M

104.64%120K

28,779.87%43.03M

-133.52%-13.15M

14.08M

-4,150.49%-24.79M

-107.01%-2.59M

-91.38%149K

-25.87%39.22M

Net issuance payments of debt

--0

----

---27.46M

--0

---24.87M

----

--0

Net common stock issuance

----

-115.83%-6.17M

---6.17M

----

-24.98%38.98M

--0

Net preferred stock issuance

--0

--40M

--20.25M

--0

----

Proceeds from stock option exercised by employees

-31.71%56K

--120K

1,934.23%3.03M

-33.04%231K

--0

-58.38%82K

--0

0.68%149K

-63.26%345K

--0

Net other financing activities

----

---110K

--0

Cash from discontinued financing activities

Financing cash flow

602.21%124.49M

104.64%120K

28,779.87%43.03M

-133.52%-13.15M

--14.08M

-4,150.49%-24.79M

-107.01%-2.59M

-91.38%149K

-25.87%39.22M

--0

Net cash flow

Beginning cash position

-22.70%88.9M

-17.82%104.8M

-27.54%78.29M

-6.41%108.04M

-29.24%80.98M

-17.52%115M

11.07%127.53M

-6.41%108.04M

-17.58%115.44M

-1.36%114.44M

Current changes in cash

488.15%131.99M

-27.38%-15.91M

35.90%26.51M

-300.34%-29.7M

57.42%-2.71M

-36.17%-34M

-150.98%-12.49M

3,400.85%19.51M

69.88%-7.42M

-992.78%-6.36M

Effect of exchange rate changes

25.00%-15K

150.00%14K

76.19%-5K

-365.00%-53K

135.56%16K

4.76%-20K

-124.35%-28K

27.59%-21K

766.67%20K

-650.00%-45K

End cash Position

172.74%220.87M

-22.70%88.9M

-17.82%104.8M

-27.54%78.29M

-29.24%80.98M

-17.52%115M

11.07%127.53M

-6.41%108.04M

Free cash flow

181.30%7.49M

-61.84%-16.03M

-85.71%-16.52M

-56.45%-51.37M

-93.62%-23.35M

-335.26%-9.22M

19.91%-9.91M

27.79%-8.9M

46.59%-32.83M

62.00%-12.06M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	248.57%13.69M	-45.99%-14.45M	-81.60%-15.92M	-61.74%-51.16M	-96.52%-23.29M	-311.69%-9.22M	19.36%-9.9M	26.12%-8.77M	47.62%-31.63M	62.34%-11.85M
Net income from continuing operations	-168.64%-24.18M	221.51%13.84M	-162.31%-56.82M	-721.02%-219.71M	-3,114.73%-177.66M	-14.05%-9M	-232.39%-11.39M	-175.28%-21.66M	237.73%35.38M	-51.85%5.89M
Operating gains losses	-86.05%-5.67M	161.63%3.91M	43.42%5.85M	756.57%138.07M	1,157.92%143.38M	-146.60%-3.05M	-236.45%-6.34M	121.86%4.08M	-999.06%-21.03M	-50.66%-13.55M
Depreciation and amortization	51.32%286K	11.36%196K	-11.17%183K	-34.50%843K	12.86%272K	-46.00%189K	-48.99%176K	-41.31%206K	2.80%1.29M	-39.90%241K
Deferred tax	----	----	----	---19M	----	----	----	----	--0	----
Other non cash items	4,300.28%15.75M	-438.50%-1.9M	4,790.91%39.81M	795.59%20.51M	3,120.58%18.78M	-33.33%358K	13.56%561K	20.41%814K	7.46%2.29M	16.83%583K
Change In working capital	76,008.82%25.81M	-1,068.25%-32.08M	-213.69%-6.37M	108.23%4.97M	44.48%-3.91M	-101.45%-34K	111.07%3.31M	121.75%5.6M	-25.28%-60.38M	81.41%-7.04M
-Change in receivables	9,019.52%29.7M	-1,488.72%-31.14M	315.89%4.48M	481.41%907K	26.65%-2.08M	-101.95%-333K	113.31%2.24M	-61.03%1.08M	105.80%156K	-9.38%-2.83M
-Change in prepaid assets	-146.75%-2.09M	43.23%1.2M	8,360.00%1.65M	-151.19%-1.27M	-144.50%-1.24M	-1,307.14%-845K	168.05%835K	-102.34%-20K	270.30%2.47M	394.90%2.78M
-Change in payables and accrued expense	-185.28%-1.81M	-294.04%-1.73M	-53.06%-7.06M	-95.71%73K	-0.24%1.68M	320.60%2.12M	-74.35%890K	-85.59%-4.61M	18.02%1.7M	109.72%1.68M
-Change in other working capital	--0	37.00%-412K	-159.37%-5.44M	108.12%5.26M	73.77%-2.27M	92.94%-976K	95.73%-654K	134.06%9.16M	-42.23%-64.71M	49.26%-8.66M
Cash from discontinued investing activities
Operating cash flow	248.57%13.69M	-45.99%-14.45M	-81.60%-15.92M	-61.74%-51.16M	-96.52%-23.29M	-311.69%-9.22M	19.36%-9.9M	26.12%-8.77M	47.62%-31.63M	62.34%-11.85M
Investing cash flow
Cash flow from continuing investing activities	-6.2M	-13,125.00%-1.59M	-102.14%-602K	330.70%34.61M	18.36%6.5M	0	87.88%-12K	194.65%28.12M	12.47%-15M	-43.54%5.49M
Net PPE purchase and sale	---6.2M	-13,125.00%-1.59M	-363.08%-602K	82.85%-206K	69.67%-64K	--0	87.88%-12K	71.43%-130K	-10.69%-1.2M	24.10%-211K
Net business purchase and sale	----	----	----	--6.56M	----	----	----	----	--0	----
Net investment purchase and sale	--0	--0	--0	304.72%28.25M	--0	--0	--0	182.54%28.25M	14.04%-13.8M	-43.00%5.7M
Cash from discontinued investing activities
Investing cash flow	---6.2M	-13,125.00%-1.59M	-102.14%-602K	330.70%34.61M	18.36%6.5M	--0	87.88%-12K	194.65%28.12M	12.47%-15M	-43.54%5.49M
Financing cash flow
Cash flow from continuing financing activities	602.21%124.49M	104.64%120K	28,779.87%43.03M	-133.52%-13.15M	14.08M	-4,150.49%-24.79M	-107.01%-2.59M	-91.38%149K	-25.87%39.22M	0
Net issuance payments of debt	--0	----	----	---27.46M	--0	---24.87M	----	----	--0	--0
Net common stock issuance	----	----	----	-115.83%-6.17M	---6.17M	----	----	----	-24.98%38.98M	--0
Net preferred stock issuance	--0	--0	--40M	--20.25M	--20.25M	--0	--0	--0	--0	----
Proceeds from stock option exercised by employees	-31.71%56K	--120K	1,934.23%3.03M	-33.04%231K	--0	-58.38%82K	--0	0.68%149K	-63.26%345K	--0
Net other financing activities	----	----	----	----	----	----	----	----	---110K	--0
Cash from discontinued financing activities
Financing cash flow	602.21%124.49M	104.64%120K	28,779.87%43.03M	-133.52%-13.15M	--14.08M	-4,150.49%-24.79M	-107.01%-2.59M	-91.38%149K	-25.87%39.22M	--0
Net cash flow
Beginning cash position	-22.70%88.9M	-17.82%104.8M	-27.54%78.29M	-6.41%108.04M	-29.24%80.98M	-17.52%115M	11.07%127.53M	-6.41%108.04M	-17.58%115.44M	-1.36%114.44M
Current changes in cash	488.15%131.99M	-27.38%-15.91M	35.90%26.51M	-300.34%-29.7M	57.42%-2.71M	-36.17%-34M	-150.98%-12.49M	3,400.85%19.51M	69.88%-7.42M	-992.78%-6.36M
Effect of exchange rate changes	25.00%-15K	150.00%14K	76.19%-5K	-365.00%-53K	135.56%16K	4.76%-20K	-124.35%-28K	27.59%-21K	766.67%20K	-650.00%-45K
End cash Position	172.74%220.87M	-22.70%88.9M	-17.82%104.8M	-27.54%78.29M	-27.54%78.29M	-29.24%80.98M	-17.52%115M	11.07%127.53M	-6.41%108.04M	-6.41%108.04M
Free cash flow	181.30%7.49M	-61.84%-16.03M	-85.71%-16.52M	-56.45%-51.37M	-93.62%-23.35M	-335.26%-9.22M	19.91%-9.91M	27.79%-8.9M	46.59%-32.83M	62.00%-12.06M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data